Consistent gene sets included E2F targets (FDR < 0.001, NES = −2.291 in TCGA BLCA; FDR < 0.001, NES = −1.158 in GSE31684; FDR < 0.001, NES = −1.622 in GSE32894), MYC targets v1 (FDR < 0.001, NES = −2.138 in TCGA BLCA; FDR = 0.14, NES = −1.174 in GSE31684; FDR < 0.001, NES = −2.116 in GSE32894), MYC targets v2 (FDR < 0.001, NES = −2.015 in TCGA BLCA; FDR = 0.082, NES = −1.309 in GSE31684; FDR < 0.001, NES = −2.009 in GSE32894), and the G2M checkpoint (FDR < 0.001, NES = −1.665 in TCGA BLCA; FDR = 0.037, NES = −1.286 in GSE31684; FDR < 0.001, NES = −1.543 in GSE32894). Here, MYC is linked to bladder transitional cell carcinoma.